Publication of Report & Accounts
22 December, 2008
Restoration of Trading on AIM and Change of Adviser
22 December, 2008
Final Results
27 November, 2008
End of Offer Period
16 September, 2008
Resignation of Director, Update on Strategic Review
29 August, 2008
News feed
requires RSS news reader
| Sareum Holdings | |
| Last Trading | 0.11 |
| Trade Time | 13:59am |
| Change | -0.01 |
| Open | 0.11 |
| Day's Range | 0.10 - 0.11 |
| Volume | 508609 |
Sareum's small molecule drug discovery expertise is building value by developing oncology drug candidates for licencing to pharmaceutical and biotechnology companies
Learn more about Sareum’s pre-clinical oncology pipeline of targeted small molecule drug candidates
Requires MS Word
Requires Adobe Acrobat Reader